222 related articles for article (PubMed ID: 8729158)
1. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers.
Gentzkow GD; Iwasaki SD; Hershon KS; Mengel M; Prendergast JJ; Ricotta JJ; Steed DP; Lipkin S
Diabetes Care; 1996 Apr; 19(4):350-4. PubMed ID: 8729158
[TBL] [Abstract][Full Text] [Related]
2. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial.
Marston WA; Hanft J; Norwood P; Pollak R;
Diabetes Care; 2003 Jun; 26(6):1701-5. PubMed ID: 12766097
[TBL] [Abstract][Full Text] [Related]
3. Healing of chronic foot ulcers in diabetic patients treated with a human fibroblast-derived dermis.
Hanft JR; Surprenant MS
J Foot Ankle Surg; 2002; 41(5):291-9. PubMed ID: 12400712
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness modeling of Dermagraft for the treatment of diabetic foot ulcers in the french context.
Allenet B; Parée F; Lebrun T; Carr L; Posnett J; Martini J; Yvon C
Diabetes Metab; 2000 Apr; 26(2):125-32. PubMed ID: 10804327
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of tissue engineering products for the management of neuropathic diabetic foot ulcers: an interim analysis.
Frykberg RG; Cazzell SM; Arroyo-Rivera J; Tallis A; Reyzelman AM; Saba F; Warren L; Stouch BC; Gilbert TW
J Wound Care; 2016 Jul; 25(Sup7):S18-S25. PubMed ID: 29027848
[TBL] [Abstract][Full Text] [Related]
6. A Prospective, Randomized, Blinded, Controlled Trial Comparing Transdermal Continuous Oxygen Delivery to Moist Wound Therapy for the Treatment of Diabetic Foot Ulcers.
Driver VR; Reyzelman A; Kawalec J; French M
Ostomy Wound Manage; 2017 Apr; 63(4):12-28. PubMed ID: 28448266
[TBL] [Abstract][Full Text] [Related]
7. A randomized clinical trial of a human acellular dermal matrix demonstrated superior healing rates for chronic diabetic foot ulcers over conventional care and an active acellular dermal matrix comparator.
Cazzell S; Vayser D; Pham H; Walters J; Reyzelman A; Samsell B; Dorsch K; Moore M
Wound Repair Regen; 2017 May; 25(3):483-497. PubMed ID: 28544150
[TBL] [Abstract][Full Text] [Related]
8. Cellular versus acellular matrix devices in the treatment of diabetic foot ulcers: Interim results of a comparative efficacy randomized controlled trial.
Tchanque-Fossuo CN; Dahle SE; Lev-Tov H; West KIM; Li CS; Rocke DM; Isseroff RR
J Tissue Eng Regen Med; 2019 Aug; 13(8):1430-1437. PubMed ID: 31070860
[TBL] [Abstract][Full Text] [Related]
9. Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: a new paradigm in wound healing.
Brem H; Balledux J; Bloom T; Kerstein MD; Hollier L
Arch Surg; 2000 Jun; 135(6):627-34. PubMed ID: 10843357
[TBL] [Abstract][Full Text] [Related]
10. A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers.
Veves A; Sheehan P; Pham HT
Arch Surg; 2002 Jul; 137(7):822-7. PubMed ID: 12093340
[TBL] [Abstract][Full Text] [Related]
11. The use of cultured dermis in the treatment of diabetic foot ulcers.
Grey JE; Lowe G; Bale S; Harding KG
J Wound Care; 1998 Jul; 7(7):324-5. PubMed ID: 9791355
[TBL] [Abstract][Full Text] [Related]
12. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
[TBL] [Abstract][Full Text] [Related]
13. High bacterial load in asymptomatic diabetic patients with neurotrophic ulcers retards wound healing after application of Dermagraft.
Browne AC; Vearncombe M; Sibbald RG
Ostomy Wound Manage; 2001 Oct; 47(10):44-9. PubMed ID: 11890078
[TBL] [Abstract][Full Text] [Related]
14. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration.
O'Meara S; Cullum N; Majid M; Sheldon T
Health Technol Assess; 2000; 4(21):1-237. PubMed ID: 11074391
[TBL] [Abstract][Full Text] [Related]
15. Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, double-blind, randomised, controlled trial.
Edmonds M; Lázaro-Martínez JL; Alfayate-García JM; Martini J; Petit JM; Rayman G; Lobmann R; Uccioli L; Sauvadet A; Bohbot S; Kerihuel JC; Piaggesi A
Lancet Diabetes Endocrinol; 2018 Mar; 6(3):186-196. PubMed ID: 29275068
[TBL] [Abstract][Full Text] [Related]
16. Effect of Cold Atmospheric Plasma Therapy vs Standard Therapy Placebo on Wound Healing in Patients With Diabetic Foot Ulcers: A Randomized Clinical Trial.
Stratmann B; Costea TC; Nolte C; Hiller J; Schmidt J; Reindel J; Masur K; Motz W; Timm J; Kerner W; Tschoepe D
JAMA Netw Open; 2020 Jul; 3(7):e2010411. PubMed ID: 32672829
[TBL] [Abstract][Full Text] [Related]
17. Clinical and microbiological efficacy of MDT in the treatment of diabetic foot ulcers.
Tantawi TI; Gohar YM; Kotb MM; Beshara FM; El-Naggar MM
J Wound Care; 2007 Oct; 16(9):379-83. PubMed ID: 17987750
[TBL] [Abstract][Full Text] [Related]
18. Multicenter, randomized controlled, observer-blinded study of a nitric oxide generating treatment in foot ulcers of patients with diabetes-ProNOx1 study.
Edmonds ME; Bodansky HJ; Boulton AJM; Chadwick PJ; Dang CN; D'Costa R; Johnston A; Kennon B; Leese G; Rajbhandari SM; Serena TE; Young MJ; Stewart JE; Tucker AT; Carter MJ
Wound Repair Regen; 2018 Mar; 26(2):228-237. PubMed ID: 29617058
[TBL] [Abstract][Full Text] [Related]
19. Treatment of venous leg ulcers with Dermagraft.
Omar AA; Mavor AI; Jones AM; Homer-Vanniasinkam S
Eur J Vasc Endovasc Surg; 2004 Jun; 27(6):666-72. PubMed ID: 15121121
[TBL] [Abstract][Full Text] [Related]
20. The importance of growth factors for the treatment of chronic wounds in the case of diabetic foot ulcers.
Buchberger B; Follmann M; Freyer D; Huppertz H; Ehm A; Wasem J
GMS Health Technol Assess; 2010 Sep; 6():Doc12. PubMed ID: 21289885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
